Skip NavigationSkip to Content

Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

  1. Author:
    Lederhofer, Julia
    Tsybovsky,Yaroslav
    Nguyen, Lam
    Raab, Julie E
    Creanga, Adrian
    Stephens,Tyler
    Gillespie, Rebecca A
    Syeda, Hubza Z
    Fisher, Brian E
    Skertic, Michelle
    Yap, Christina
    Schaub, Andrew J
    Rawi, Reda
    Kwong, Peter D
    Graham, Barney S
    McDermott, Adrian B
    Andrews, Sarah F
    King, Neil P
    Kanekiyo, Masaru
  2. Author Address

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21702, USA., Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: kanekiyom@nih.gov.,
    1. Year: 2024
    2. Date: Mar 12
    3. Epub Date: 2024 02 28
  1. Journal: Immunity
    1. 57
    2. 3
    3. Pages: 574-586.e7
  2. Type of Article: Article
  1. Abstract:

    Continuously evolving influenza viruses cause seasonal epidemics and pose global pandemic threats. Although viral neuraminidase (NA) is an effective drug and vaccine target, our understanding of the NA antigenic landscape still remains incomplete. Here, we describe NA-specific human antibodies that target the underside of the NA globular head domain, inhibit viral propagation of a wide range of human H3N2, swine-origin variant H3N2, and H2N2 viruses, and confer both pre- and post-exposure protection against lethalĀ H3N2 infection in mice. Cryo-EM structures of two such antibodies in complex with NA reveal non-overlapping epitopes covering the underside of the NA head. These sites are highly conserved among N2 NAs yet inaccessible unless the NA head tilts or dissociates. Our findings help guide the development of effective countermeasures against ever-changing influenza viruses by identifying hidden conserved sites of vulnerability on the NA underside. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.immuni.2024.02.003
  2. PMID: 38430907
  3. PMCID: PMC10962683
  4. WOS: 001225838700001
  5. PII : S1074-7613(24)00079-7

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel